Literature DB >> 28496795

Atrial Remodelling : Role in Atrial Fibrillation Ablation.

Herko Grubitzsch1, Wilhelm Haverkamp2.   

Abstract

There have been considerable advances in understanding the relationship of atrial fibrillation (AF) and atrial remodelling suggesting that remodelling states have a significant impact on treatment results. Therefore, we reviewed the literature about the role of atrial remodelling in AF treatment, focussing on AF ablation. Atrial fibrillatory activity, dominant frequencies (DF), complex fractionated atrial electrograms (CFAE) as well as function, volume, and fibrosis of the - especially left - atrium are most important characteristics for electrical, contractile, and structural remodelling predicting success of AF treatment. In particular, the results of AF ablation, either using catheter-based or surgical techniques, predominantly depend on the degree of structural remodelling, namely dilatation and fibrosis of the left atrium. The available data suggest that recognizing parameters of remodelling as predictors for AF treatment facilitates differentiation between patients who may or may not benefit from the procedure and individualization of AF treatment by adapting lesion sets, by ablating additional targets, by reducing left atrial size, or by applying extended pharmacological treatment.

Entities:  

Year:  2012        PMID: 28496795      PMCID: PMC5153159          DOI: 10.4022/jafib.691

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  76 in total

1.  The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation.

Authors:  A Marc Gillinov; Jon Sirak; Eugene H Blackstone; Patrick M McCarthy; Jeevanantham Rajeswaran; Gosta Pettersson; F Joseph Sabik; Lars G Svensson; Jose L Navia; Delos M Cosgrove; Nassir Marrouche; Andrea Natale
Journal:  J Thorac Cardiovasc Surg       Date:  2005-10-26       Impact factor: 5.209

2.  Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation.

Authors:  U Schotten; J Ausma; C Stellbrink; I Sabatschus; M Vogel; D Frechen; F Schoendube; P Hanrath; M A Allessie
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

3.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation.

Authors:  A Goette; T Staack; C Röcken; M Arndt; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

4.  Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability.

Authors:  P Attuel; R Childers; B Cauchemez; J Poveda; J Mugica; P Coumel
Journal:  Int J Cardiol       Date:  1982       Impact factor: 4.164

5.  Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis.

Authors:  Scott D Barnett; Niv Ad
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

6.  Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand.

Authors:  Ulrich Schotten; Mattias Duytschaever; Jannie Ausma; Sabine Eijsbouts; Hans-Ruprecht Neuberger; Maurits Allessie
Journal:  Circulation       Date:  2003-03-18       Impact factor: 29.690

7.  Spatiotemporal characterization of atrial activation in persistent human atrial fibrillation: multisite electrogram analysis and surface electrocardiographic correlations--a pilot study.

Authors:  Samer R Dibs; Jason Ng; Rishi Arora; Rod S Passman; Alan H Kadish; Jeffrey J Goldberger
Journal:  Heart Rhythm       Date:  2008-01-29       Impact factor: 6.343

8.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

Authors:  W B Kannel; P A Wolf; E J Benjamin; D Levy
Journal:  Am J Cardiol       Date:  1998-10-16       Impact factor: 2.778

9.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

10.  Structural correlate of atrial fibrillation in human patients.

Authors:  Sawa Kostin; Gabi Klein; Zoltan Szalay; Stefan Hein; Erwin P Bauer; Jutta Schaper
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.